Qatar experience of standard risk breast cancer screening program (BCSP).

2014 ◽  
Vol 32 (26_suppl) ◽  
pp. 18-18
Author(s):  
Salha M. Bujassoum ◽  
Reena Alassam ◽  
Hekmat Bugrein
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma ◽  
Screening Program ◽  
Arab World ◽  
Breast Cancer Incidence ◽  
Incidence Rates ◽  
Distributed Model ◽  
Age Group ◽  
Detection Rates ◽  
Triple Assessment

18 Background: Qatar has one of the highest age-adjusted breast cancer incidences in the Arab world. Although this is much lower than the incidence in the West. Breast-cancer incidence in Qatar was 45 per 100,000 in 2003 to 2007.These higher incidence rates in Qatar are mainly due to the growing population. The prevalent age group, for Qatari and non-Qatari patients, was age 40 to 50. This suggests that the age-specific incidence of breast cancer in Qatari women is unlike the pattern usually seen in Western nations where median age at diagnosis is 61 years, moreover the diagnosis is often at advanced stages of breast cancer. These factors led to establishment the first hospital based (BCSP) in Qatar. It uses a distributed model of mammography service. The program launched 2008, accepts eligible asymptomatic women at ages 40 to 69. Methods: Retrospective study was done during the period from April 2008 to December 2013. Our aim is to describe our experience of (BCSP) in Qatar and to monitor performance indicators. Our (BCSP) includes an office call and recall as well as triple assessment. We also discuss positive cases in multidisciplinary meeting. Results: Total number of screened women was 4,264 with an increasing participation, year by year. Out of these, Qatari patient’s accounts for 1,145, and non Qatari for 3,119. The age group of cases was (43 to 51). Total breast biopsies were 82, of which 45 were positive of breast carcinomas, (37) invasive ductal carcinoma, (8) noninvasive ductal carcinoma. The invasive cancer detection rate was 8.2 %. The positive predictive value (PPV) was 46%. Sensitivity value has improved from 51% in 2008 to 70% in 2012 as well as specificity value that has increased from 77% in 2008 to 83% in 2012. Conclusions: Public acceptance of (BCSP) in Qatar gradually increased and detection rates are higher than western countries. We’re detecting biologically aggressive tumors at younger age groups. We’ve a unique population and we need to utilize our data and evidence based medicine to guide policy makers and women to make the correct decision towards (BCSP).

Breast cancer incidence in a large cohort of Peruvian women affiliated to a pre-paid system.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e12570-e12570
Author(s):  
Juan F. Suazo ◽  
Priscila I. Valdiviezo ◽  
Claudio J. Flores ◽  
Jorge Iberico ◽  
Joseph A. Pinto ◽  
...  
Keyword(s):  
Breast Cancer ◽  
At Risk ◽  
General Population ◽  
Incidence Rate ◽  
Breast Cancer Incidence ◽  
Age Groups ◽  
Cumulative Risk ◽  
Incidence Rates ◽  
Specific Rate ◽  
Age Group

e12570 Background: Breast cancer (BC) is the second most common malignancy and the leading cause of death by cancer in Peruvian women (age-standarized rate [ASR] of 34 new cases/100,000 women estimated by GLOBOCAN 2008). The purpose of this study was to assess the incidence of BCin acohort ofwomenat Oncosalud, an oncologic pre-paid system that currently has 600,000 affiliates. Methods: We evaluated a dynamic cohort (period 1989 to 2011) of women affiliatedat Oncosalud – AUNA, an oncologic prepaid system.The crude incidence rate per year (number of new cases/women at risk), the specific rate according to age (number of new cases / persons-year) and cumulative risk were calculated. Results: Overall, during the assessment period, the BC incidence rate per year was 175.6 and the ASR incidence was 111.9 per 100,000 affiliates respectively. In our cohort of affiliates there were no BC cases before 1993 (with 907 women at risk for that year). The highest incidence rate was 177.6 registered in 1997 (11,822 women at risk). Incidence rates started decreasing in 2003 (169.2 with a population at risk of 39,593 women). The lowest incidence was 71.5, registered in 2011 (279,680 women at risk).According to age-groups, there were no BC cases under20 years old. Specificincidence ratesper age-group increases from the 30 year old-group (55.8). The peak of BC incidence was between 70 to 74 years old (407.4). In the same way, the cumulative risk increases after 30 years old. Conclusions: In our cohort of affiliates, the incidence of BC is greater than the general population, it could be due to the process of negative selection; however, specific incidence rates per age-group and cumulative risk are increased after 30 years, as seen in the general population.

scholarly journals Comparison of ultrasound and histopatological findings breast cancer between women aged below and above 40 years.

2021 ◽  
Vol 58 (1) ◽  
pp. 5713-5722
Author(s):  
Suraini Mohamad Saini Et al.
Keyword(s):  
Breast Cancer ◽  
Breast Carcinoma ◽  
Ductal Carcinoma ◽  
Tumour Size ◽  
Breast Cancer Incidence ◽  
Age Group ◽  
Her2 Receptor ◽  
Cross Sectional ◽  
Common Features ◽  
Ultrasound Findings

 Breast cancer is the most common cancer among females, but breast cancer incidence in young women is low. There are limited studies of breast cancer in this age group in Malaysia, while there are conflicting data regarding these women's prognosis compared to older patients. This study describes the common features presented by breast carcinoma on histopathological and ultrasound findings. Objective: To compare the ultrasound findings and histopathological characteristics of breast cancer for women aged below 40 years and those aged 40 years and above. Methodology: This was a retrospective, cross-sectional study using secondary data, in which the data was collected respectively from patient's clinical histories, radiology findings, and histopathology reports of patients with breast cancer in Hospital Serdang from 1 January 2009 until 31 December 2018. Patients were divided into two age groups (ages below 40, ages 40 and above).  Results: 205 patients were included in this study. The most common type of breast carcinoma is invasive ductal carcinoma. Common features are grade II breast cancer cells, DCIS high grade, stage 2 (TNM), tumour size of T2 and lymph node invasion. The majority of tumours are positive with oestrogen receptor, progesterone receptor, and HER2 receptor. Conclusion: Younger age group has a similar feature with the older age group, except they have late stage and progesterone negativity. There is no significant association between age group, ultrasound, histological features, and breast carcinoma receptors. Keywords: ultrasound breast, histopathological, breast cancer

PROFICIENT STRIDES AND INHERENT LIMITATIONS IN CURRENT DIAGNOSTIC STRATEGY OF BREAST MASS

2021 ◽  
pp. 59-61
Author(s):  
Harahsheh Hend ◽  
Al Shurbaji Duaa ◽  
Alrabadi Maha ◽  
Al-shurafat Mohammad ◽  
Lababneh Muhand ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma ◽  
Breast Cancer Incidence ◽  
Female Breast Cancer ◽  
Incidence Rates ◽  
Breast Mass ◽  
Diagnostic Strategy ◽  
Breast Cancers ◽  
Systematic Screening ◽  
Medical Advances

Breast masses might be a mass discovered by patients incidentally during breast self-examination or else by the physician during routine physical examination. These masses have a variable etiology and nature. while, Fibroadenoma considered the most common benign breast mass, contrary, invasive ductal carcinoma is the most common malignancy [1]. Although, the vast majority of these masses are benign, still breast cancer is the furthermost frequently resulting malignancy in females worldwide having an age-standardized incidence rate (ASR) of 39.0 per 100,000 females, and the second leading cause of cancer deaths in women [2-4]. In spite of most breast cancers occur in women older than 50 years, one third of women diagnosed with breast cancer between 1996 and 2000 were younger than 50 years [5,6]. Contempt of medical advances and assuring treatment regime, morbidity and mortality due to breast cancer has seen no signicant changes in developing countries. In the US in 2020, estimations reach 276,480 new cases of invasive breast cancer in women ,and an additional 48,530 cases of ductal carcinoma in situ diagnosed in women [7]. Also, an estimated mortality of 42,170 female patients with breast cancer will occur in 2020. Invasive female breast cancer incidence rates trends increased slightly, by 0.3% per year [2,6,8]. This might probably be due to lack of systematic screening and early detection

scholarly journals MEDICAL AND STATISTICAL CHARACTERISTICS OF BREAST CANCER IN ST. PETERSBURG FEMALE RESIDENTS

2019 ◽  
Vol 6 (2) ◽  
pp. 32-39
Author(s):  
N. S. Romanenkov ◽  
V. V. Hizha ◽  
K. N. Movchan ◽  
U. M. Morozov ◽  
R. M. Gedgafov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Standard Deviation ◽  
Cancer Patients ◽  
Ductal Carcinoma ◽  
Breast Cancer Incidence ◽  
Incidence Rates ◽  
Statistical Characteristics ◽  
High Tech ◽  
Breast Cancer Patients ◽  
Statistical Parameters

Purpose. To analyze the main medical and statistical parameters, allowing to evaluate the results of breast cancer treatment. Patients and methods. Data on 4689 breast cancer (BC) patients were analyzed retrospectively. Inclusion criteria were: female, residence in St. Petersburg, diagnosis of BC established in 2011, 2012. The study also includes information on the options of BC surgical treatment, one-year mortality in breast cancer patients and index of the contingent accumulation in St. Petersburg in 2011–2017. For statistical data processing Statistica 12.0 for Windows, Population Cancer Register and MedInfo-4 were used. The differences in the groups of studies were considered statistically significant at p < 0.05.Results. The prevalence of breast cancer among women in St. Petersburg varies from 532.6 per 100 000 population in 2011 to 545.00/0000 in 2012. In 2011 the incidence of BC in women in St. Petersburg was 46.210/0000 (standard deviation 1.05) and in 2012 – 49.50/0000 (standard deviation 1.05). The mean age of breast cancer patients is 64 years (standard deviation 12.25). Localization of a tumor in one of the glands was found in 4617 (98.5%) clinical observations. In 2,846 (60.7%) cases, the tumor sizes varied from 2 to 5 cm. Signs of infiltrative ductal carcinoma were histologically verified in 3689 (80%) cases. The proportion of single-stage breast reconstruction after mastectomy in the overall structure of surgeries in breast cancer patients increased in 2011–2017 more than 6.5 times. The 5-year survival rate in study groups was 64.4% and 63.3%. Conclusions The main statistical parameters of medical care (MC) analysis in breast cancer patients in St. Petersburg in 2011–2017 allow to state generally positive trends in the anticancer fight organization. The increase of the breast cancer incidence rates is partly due to the improved quality of examination and treatment of patients through the creation in the city of a system of high-tech MC, as well as to the particularly wary of doctors in detecting breast tumors.

scholarly journals Implementation of the German Mammography Screening Program (German MSP) and First Results for Initial Examinations, 2005-2009

Breast Care ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. 183-187 ◽  
Author(s):  
Daniela Malek ◽  
Vanessa Kääb-Sanyal
Keyword(s):  
Mammography Screening ◽  
Ductal Carcinoma ◽  
Screening Program ◽  
Breast Cancer Incidence ◽  
Performance Outcomes ◽  
Long Term Effects ◽  
Screening Process ◽  
Federal States ◽  
Target Values ◽  
Mammography Screening Program

Background: The German Mammography Screening Program (German MSP) is population-based and intended for women aged 50-69 years (approximately 10.5 million). The program started in 2005 and was implemented within 5 years. This article describes the implementation, structure, and screening process, and presents the results of initial examinations for the prevalence phase. Methods: Data were collected annually from invitation centers (invitation, attendance), screening units (performance, outcomes), and cancer registries (incidence). Results: In 2009, 92% of all annually eligible women were invited; 50% of the annually eligible population participated. The total cancer detection rate in the period of 2005-2009 was 8.1/1,000; the corresponding recall rate was 5.9%. 19.6% of detected cancers were ductal carcinoma in situ; 76.7% of invasive cancers were ≤ 20 mm in size, 30.2% were ≤ 10 mm, and 75.3% were node-negative. During the implementation period, incidence increased by 37 and 56% in the old and new federal states, respectively. Incidence rates decreased following the prevalence phase. Conclusion: The German MSP was successfully implemented. The results of the prevalence phase meet the target values of the European guidelines. Proper functioning of the program is also verified by its effects on breast cancer incidence. To draw reliable conclusions regarding the long-term effects of the program, results from the routine screening rounds have to be awaited.

Sign in / Sign up

Export Citation Format

Share Document